Naftazone

DB13680ApprovedSmall molecule

Naftazone is a naphthoquinone derivative indicated in the treatment of varicose veins, hemorrhoids, and superficial thrombophlebitis. A medication used to treat spider veins and hemorrhoids.

Formula / weight: C₁₁H₉N₃O₂ · 215.212 g/mol (avg)

Resolves to

Compound

UNII15B0523P5LCAS15687-37-3ChEMBLCHEMBL2106794ChEBI134890

Clinical / RWD

RxNorm31475ATCC05CX02

Structure

InChIKeyTZGBBMBARSFJBG-UKTHLTGXSA-NSMILESNC(=O)N\N=C1/C=CC2=CC=CC=C2C1=O

What you can answer from here — as of July 07, 2026

3Structured indicationsCondition, population, route and combination as fields, not prose

2ContraindicationsEach with its own population and attribute set

3Marketed productsAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 8 drug categories

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Naftazone, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account